You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches
Dermatology
On demand events

The Benefits of Early Intervention in Reducing the Burden of Disease in Children With Atopic Dermatitis

This page presents educational material, infographics, and video highlights from our recent ADVENT symposia exploring the pathophysiology of type 2 inflammation and atopic dermatitis, the burden of disease leading to cumulative life course impairment (CLCI), and the risk of the atopic march in pediatric patients with atopic dermatitis.
Perla Lansang
Christine Bangert
Amy Paller
MD
Perla Lansang +2 more

On demand materials

Explore the Global Burden of Pediatric AD (PEDISTAD)
Dermatology
interactivity

Explore the Global Burden of Pediatric AD (PEDISTAD)

CCL17 (TARC): A Key Player and Biomarker in Atopic Dermatitis
Dermatology
Infographic

CCL17 (TARC): A Key Player and Biomarker in Atopic Dermatitis

Disease Modification in AD
Dermatology
expert video

Disease Modification in AD

Persistence of AD From Childhood Into Adulthood
Dermatology
expert video

Persistence of AD From Childhood Into Adulthood

Identification and Management of AD Uncontrolled With Topical Therapies in Children
Dermatology
expert video

Identification and Management of AD Uncontrolled With Topical Therapies in Children

The Role of Type 2 Inflammation in Multiple Disease Trajectories
Dermatology
Infographic

The Role of Type 2 Inflammation in Multiple Disease Trajectories

Learning objectives

  • Understand the burden that atopic dermatitis places on pediatric patients, and how that burden can worsen throughout life if the disease is not controlled
  • Describe how atopic dermatitis can lead to systemic inflammation and the development of other atopic comorbidities
  • Discuss the benefits of early intervention in AD and the potential for disease modification
Tags
expert insightssymposiummechanism of disease
MAT-GLB-2502438 - 1.0 - 05/2025

About these experts

Dermatology
MD

Perla Lansang

The Hospital for Sick Children Toronto, Canada

Dermatology
MD

Christine Bangert

Medical University of Vienna General Hospital, Vienna, Austria

Dermatology
MD, MS

Amy Paller

Walter J. Hamlin Professor and Chair of Dermatology; Professor of Pediatrics at Northwestern University, Evanston, Illinois, US

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: ThailandChange country/region